Unknown

Dataset Information

0

Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia.


ABSTRACT: We show that imatinib, nilotinib, and dasatinib possess weak off-target activity against RAF and, therefore, drive paradoxical activation of BRAF and CRAF in a RAS-dependent manner. Critically, because RAS is activated by BCR-ABL, in drug-resistant chronic myeloid leukemia (CML) cells, RAS activity persists in the presence of these drugs, driving paradoxical activation of BRAF, CRAF, MEK, and ERK, and leading to an unexpected dependency on the pathway. Consequently, nilotinib synergizes with MEK inhibitors to kill drug-resistant CML cells and block tumor growth in mice. Thus, we show that imatinib, nilotinib, and dasatinib drive paradoxical RAF/MEK/ERK pathway activation and have uncovered a synthetic lethal interaction that can be used to kill drug-resistant CML cells in vitro and in vivo.

SUBMITTER: Packer LM 

PROVIDER: S-EPMC3951999 | biostudies-literature | 2011 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia.

Packer Leisl M LM   Rana Sareena S   Hayward Robert R   O'Hare Thomas T   Eide Christopher A CA   Rebocho Ana A   Heidorn Sonja S   Zabriskie Matthew S MS   Niculescu-Duvaz Ion I   Druker Brian J BJ   Springer Caroline C   Marais Richard R  

Cancer cell 20111201 6


We show that imatinib, nilotinib, and dasatinib possess weak off-target activity against RAF and, therefore, drive paradoxical activation of BRAF and CRAF in a RAS-dependent manner. Critically, because RAS is activated by BCR-ABL, in drug-resistant chronic myeloid leukemia (CML) cells, RAS activity persists in the presence of these drugs, driving paradoxical activation of BRAF, CRAF, MEK, and ERK, and leading to an unexpected dependency on the pathway. Consequently, nilotinib synergizes with MEK  ...[more]

Similar Datasets

2021-12-31 | E-MTAB-10048 | biostudies-arrayexpress
2022-02-22 | E-MTAB-10261 | biostudies-arrayexpress
| S-EPMC4334758 | biostudies-literature
| S-EPMC5823647 | biostudies-literature
| S-EPMC8393793 | biostudies-literature
| S-EPMC3000369 | biostudies-literature
| S-SCDT-10_15252-EMMM_202318852 | biostudies-other
| S-EPMC6168748 | biostudies-literature
| PRJEB42703 | ENA
| S-EPMC5440865 | biostudies-other